AbbVie is aiming to position Vuity as a first-line option for people newly-diagnosed with mild-to-moderate presbyopia, either as an alternative to reading glasses or as an add-on that can give ...
The company sees AGN-190584 as being a first-line treatment for people newly-diagnosed with mild-to-moderate presbyopia, or as an adjunct to reading glasses for people who want more flexibility in ...
India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia. These new eye drops, known as PresVuand manufactured by Mumbai-based ...
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia. Smith said that ...
008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...
Tenpoint plans to submit an FDA new drug application in the first half of 2025. Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase ...
In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients with presbyopia for up to eight hours. The top-line results come f ...